StockData
Alterity Therapeutics Ltd logo

Alterity Therapeutics Ltd (ATHE) stock

ATHENasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRNAF
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Aug 28, 2026Score 5/30
$1.86−0.09 (-4.85%)

Close on Nov 17, 2026Market cap $33.80MP/E –Yield –

Alterity Therapeutics total assets

Total assets on the balance sheet at the end of each period.

Alterity Therapeutics's total assets was A$46.02M at Jun 30, 2026. For fiscal 2026 it was A$46.02M, down 0.0% from the year before. The highest annual figure on record is A$46.03M in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2026Jun 30, 2026A$46.02M-0.0%
FY2025Jun 30, 2025A$46.03M+139.4%
FY2024Jun 30, 2024A$19.22M-29.6%
FY2023Jun 30, 2023A$27.32M-34.0%
FY2022Jun 30, 2022A$41.36M+23.2%
FY2021Jun 30, 2021A$33.59M+239.0%
FY2020Jun 30, 2020A$9.91M-50.2%
FY2019Jun 30, 2019A$19.91M+6.3%
FY2018Jun 30, 2018A$18.73M-25.9%
FY2017Jun 30, 2017A$25.28M–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 2026A$46.02M+11.3%
Q4 FY2025CQ2 2025Jun 30, 2025A$46.03M+2.4%
Q4 FY2024CQ2 2024Jun 30, 2024A$19.22M-42.8%
Q4 FY2023CQ2 2023Jun 30, 2023A$27.32M-27.0%
Q4 FY2022CQ2 2022Jun 30, 2022A$41.36M+317.5%
Q2 FY2022CQ4 2021Dec 31, 2021A$44.93M+125.7%
Q4 FY2021CQ2 2021Jun 30, 2021A$33.59M+79.4%
Q2 FY2021CQ4 2020Dec 31, 2020A$37.41M+48.0%
Q4 FY2020CQ2 2020Jun 30, 2020A$9.91M–
Q4 FY2019CQ2 2019Jun 30, 2019A$19.91M–
Q4 FY2018CQ2 2018Jun 30, 2018A$18.73M–
Q4 FY2017CQ2 2017Jun 30, 2017A$25.28M–

More Alterity Therapeutics figures

See a number that looks wrong?